Clearwave Capital, LLC has filed its latest 13F-HR report with the SEC, revealing its investment holdings as of September 30, 2026. The report shows that the firm manages a total portfolio valued at $190.4 million across 176 positions. This filing is significant as it provides insights into Clearwave's investment strategies and market positioning.
Clearwave Capital, based in Upland, California, is an investment management firm that focuses on various sectors, including technology and healthcare. The firm has been active in the market, with recent filings indicating a consistent approach to portfolio management. The company’s latest filing, accession number 0001214659-26-013248, was submitted on October 27, 2026.
What the Filing Says
The filing highlights key positions held by Clearwave Capital, including notable investments in major corporations. The report lists holdings in companies such as 3M Co, Abbott Laboratories, and Alphabet Inc, among others. For instance, Clearwave holds 2,185 shares of 3M Co, valued at approximately $358,689, and 2,470 shares of Abbott Laboratories, valued at around $244,136.
Corey Cunningham, Managing Partner at Clearwave, signed the report, indicating the firm's commitment to transparency and regulatory compliance. The filing does not detail specific changes in investment strategy or future plans but reflects the firm's overall market positioning.
Impact
This filing may have implications for various stakeholders, including investors, analysts, and competitors in the investment management industry. By revealing its holdings, Clearwave provides a glimpse into its investment philosophy and market outlook, which could influence investor sentiment and competitive strategies.
What's Next
Details were not available in the SEC filing regarding future actions or upcoming filings. However, investors and analysts will likely monitor Clearwave's next moves closely as they assess market trends and the firm's performance in the evolving investment landscape.